Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease

Boehringer Ingelheim

Status: Completed

Conditions: Parkinson Disease

Treatments: Drug: Mirapex LA

Study type: Observational

Funder types: Industry

Identifiers

NCT01525641

248.680

Details and patient eligibility

About

Post-marketing surveillance (PMS) to investigate the safety and efficacy of long-term daily use of Mirapex®-LA Tablets in patients with Parkinson's disease.

Enrollment: 615 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with Parkinson's disease who have never been treated with Mirapex LA Tablets before enrolment will be included.

Exclusion criteria

• None

Trial design

615 participants in 1 patient group

Patient with Parkinson's Disease

Treatment:

Drug: Mirapex LA